O
Ocuphire Pharma
OCUP
1.86000
USD
-0.13
(-6.53%)
مفتوح الان
حجم التداول
35
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
34,843,931
العنوان: Ocuphire Pharma
القطاع: Healthcare
الصناعة: Biotechnology
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.